Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath Sells 94 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report) CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Jamie Samath also recently made the following trade(s):

  • On Tuesday, December 10th, Jamie Samath sold 270 shares of Intuitive Surgical stock. The shares were sold at an average price of $540.15, for a total value of $145,840.50.
  • On Friday, November 29th, Jamie Samath sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00.
  • On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The shares were sold at an average price of $542.06, for a total value of $58,542.48.
  • On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00.
  • On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.89, for a total value of $145,230.41.

Intuitive Surgical Trading Down 0.2 %

NASDAQ:ISRG opened at $572.71 on Thursday. The firm has a market capitalization of $203.99 billion, a price-to-earnings ratio of 92.08, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business’s fifty day moving average price is $548.70 and its 200 day moving average price is $507.04.

Institutional Trading of Intuitive Surgical

Several institutional investors have recently made changes to their positions in the stock. Mirador Capital Partners LP raised its stake in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after purchasing an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the 4th quarter valued at approximately $82,517,000. Exome Asset Management LLC boosted its stake in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp increased its stake in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Jefferies Financial Group lifted their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday. UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday. Finally, BTIG Research lifted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Get Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.